where to next?, page-885

I thought that individual products are either TGA-approved or not. Any product manufactured by any company like PCI is not approved until TGA approves it. So, if AusCann get the "promised" capsules manufactured by PCI, this product will be not approved automatically by TGA. I see many saying that AusCann has this and that but there is no evidence at all. The truth remains that AusCann has no "evidence" of having products, patients, network of doctors, trials, published papers ... AGH has products, patients and doctors and the number of patients and doctors are growing quickly. And this looks like the difference that causes the different directions for share prices. Let's wait to see the news about appointment of CEO will create any change in sentiment for investors towards AusCann. It might become just another small pop today and a chance for the big boys to unload more.